Similarly, glucose uptake is also reduced by BBR, via inhibition glucose transporter 1 (GluT1), lactate dehydrogenase-A (LDH-A), and hexokinase-2 (HK-2) expression, which induces apoptosis and thus inhibits tumor growth and invasiveness [25]. Here, SLC2A1 is linked to neoplasm.